BETTER/SMARTER.ME
Supporting Self-Enhancement Science for the Success of Society
Logo
The Institute for the Future of Human Potential
☰
VOLUME XXII | OCT 2018

Topographic Markers Drive Proteinopathies to Selection of Target Brain Areas at Onset in Neurodegenerative Dementias

Dr. David Lowemann
Dr. David Lowemann
Dr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering

Carlo Abbate

Read Full Article (External Site)

Related posts:

  1. Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson’s Disease
  2. Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
  3. Modeling Reference Production as the Probabilistic Combination of Multiple Perspectives
  4. Abnormal Functional Connectivity Density in Amyotrophic Lateral Sclerosis